Thursday, July 7, 2022, 11:30 AM – 1 PM EDT

Ighovwerha Ofotokun, MD, MSc, Professor of Medicine and Professor of Behavioral Sciences and Health Education

“Post-Acute Sequalae of COVID-19 . . . or Long COVID”

Clinician-scientist Dr. Igho Ofotokun has long been involved in Emory’s work with emerging infectious diseases and their consequences or sequalae. He has now been chosen as a Principal Investigator of the Atlanta hub of the nationwide NIH-funded initiative, Researching COVID to Enhance Recovery (RECOVER). Aimed at studying the long-term post-acute-sequalae of COVID-19 (PASC), the initiative seeks to understand the phenomenon that has come to be known as Long COVID so as to treat it better and perhaps prevent its occurrence. Today, Dr. Ofotokun will discuss what we currently know about the problem, including the burden of the lingering disease, the common clinical manifestations, the potential pathobiology, and the research effort he is helping to lead here at Emory and at other Atlanta-area institutions.

Ighovwerha Ofotokun, MD, MSc, Professor of Medicine and Professor of Behavioral Sciences and Health Education

“Post-Acute Sequalae of COVID-19 . . . or Long COVID”

Clinician-scientist Dr. Igho Ofotokun has long been involved in Emory’s work with emerging infectious diseases and their consequences or sequalae. He has now been chosen as a Principal Investigator of the Atlanta hub of the nationwide NIH-funded initiative, Researching COVID to Enhance Recovery (RECOVER). Aimed at studying the long-term post-acute-sequalae of COVID-19 (PASC), the initiative seeks to understand the phenomenon that has come to be known as Long COVID so as to treat it better and perhaps prevent its occurrence. Today, Dr. Ofotokun will discuss what we currently know about the problem, including the burden of the lingering disease, the common clinical manifestations, the potential pathobiology, and the research effort he is helping to lead here at Emory and at other Atlanta-area institutions.